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ABSTRACT 
 
Aspergillosis spores enter buildings during renovation or construction. Recent 
research shows a causal link between new construction in existing healthcare facilities 
and increased infection rates in at risk patients. Aspergillosis is a dangerous pathogen 
that can lead to death, especially in immune suppressed patients, who are most at risk. 
Not all patients have the same risk level of infection, but infection control is an 
important step in the construction process, as the Aspergillosis spores are transmitted on 
dust particles, to reduce the risk of fatal infections. Infection control barriers have been 
largely adopted for new hospital construction at an existing facility to reduce the 
incidence of infections caused by construction dust borne pathogens. Previous research 
on construction barriers at TAMU showed that a properly placed plastic sheet barrier 
stopped all particle movement for a pressure differential of 105 kiloPascals measured 
over twenty-four hours. It is not possible to maintain a sealed barrier during all 
construction, although this is the most effective means of stopping dust transmission 
intra-building, doors are often needed to access the construction site safely. This study 
extends the work on the sealed barrier to introduce a small door into the sealed barrier. 
The door area is five percent of the wall area. The purpose of the experiment is to study 
the rate of particle movement, size range of one to ten microns, through the barrier with 
a door present under a defined set of standard air flow conditions. The door will be 
opened and closed at different times during the experimental period. No dust could be 
observed to have moved through the doorway under the present study conditions. The 
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results show that it is not a sufficient condition to assume that measuring air exchange 
rates is sufficient to determine the rate of dust movement; it appears to have an air 
surface velocity dependence that was not studied in this research. Future research is 
recommended to include the air velocity movement as a variable in the study.  
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NOMENCLATURE 
 
These definitions are derived from the earlier research work by (Bassett, 2013): 
• AIA American Institute of Architects 
• APIC  Association for Professionals in Infection Control 
• Aspergillus: Aspergillus spp. and in particular Aspergillus fumigatus are fungi 
that play an essential role in recycling environmental carbon and nitrogen. Their 
natural ecological niche is the soil, wherein it survives and grows on organic 
debris. Although A. fumigatus is not the most prevalent fungus in the world, it is 
one of the most ubiquitous of those with airborne spores. The spores released 
into the atmosphere have a diameter small enough (2 to 3 μm) to reach deep into 
the lungs. Once the spores are in the air, their small size makes them buoyant, 
tending to keep them airborne both indoors and outdoors. Environmental surveys 
indicate that all humans will inhale at least several hundred Aspergillus spores 
per day. (Latge, 1999) 
• Aspergillosis: Aspergillosis is a disease caused by the inhalation of the fungus 
Aspergillus, and usually this inhalation results in disease in people with lung 
diseases or weakened immune systems. The spectrum of illness includes allergic 
reactions, lung infections, and infections in other organs (CDC, 2012a) 
• Antifungal: A drug used to treat infections caused by fungi.  
• CDC: “The Center for Disease Control and Prevention is the nation's disease 
prevention and wellness promotion agency, protecting people's health and safety, 
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providing credible information to enhance health decisions, and improving 
health through strong partnerships. CDC's work encompasses a wide range of 
health threats, including infectious and chronic diseases, injuries, birth defects, 
food and water safety, bioterrorism, environmental hazards, and occupational 
health and safety. CDC also administers funding for state and local health 
departments, community-based organizations and academic institutions for a 
wide array of public health programs and research”(CDC, 2012b). 
• Construction: can be defined as a building of structures, or the additions, 
alterations, expansions, reconstruction, or renovations to existing buildings. 
Construction may also include any maintenance, repairs or installation work to 
mechanical, electrical, or plumbing systems that form a part of a building system.  
• Immunosuppressed: A state in which the patient’s immune system is weakened 
due to their condition and treatment. Their body’s immune system or ability to 
fight off infection is impaired or not effective, making the person more 
susceptible and vulnerable to infection. This condition is also known as being 
immune-compromised. 
• Infection Control: Policies or procedures implemented by a healthcare facility 
and carried out by construction professionals to minimize the risk of spreading 
infections. These procedures are implemented for the protection of patients 
within the facility. 
• Barrier: A fundamental component of infection control; barriers are the first line 
of defense to prevent the spread of infection within a hospital. During a time of 
 viii 
 
construction activity, barriers isolate the construction area from the treatment 
area.  
• Nosocomial Infections: Infections contracted within the hospital that is unrelated 
to the patient’s initial illness or injury. Nosocomial infections are also known as 
hospital-acquired infections. Recent research links nosocomial infections to 
occur during a time of construction within the healthcare facility.  
• ASHRAE   Formerly the American Society of Heating, Refrigerating and Air 
Conditioning Engineers. Founded in 1894, is a building technology society with 
more than 54,000 members worldwide. The society and its members focus on 
building system, energy efficiency, indoor air quality, refrigeration and 
sustainability within the industry. 
 ix 
 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT .................................................................................................................. ii 
DEDICATION.............................................................................................................. iv 
ACKNOWLEDGEMENTS ........................................................................................... v 
NOMENCLATURE ..................................................................................................... vi 
TABLE OF CONTENTS .............................................................................................. ix 
LIST OF FIGURES ...................................................................................................... xi 
LIST OF TABLES ...................................................................................................... xiv 
CHAPTER I  INTRODUCTION ................................................................................... 1 
Background to the Study ............................................................................................ 1 
Problem Statement ..................................................................................................... 3 
Research Objectives ................................................................................................... 3 
Hypothesis ................................................................................................................. 3 
Study Limitations ....................................................................................................... 3 
Study Assumptions .................................................................................................... 4 
Significance ............................................................................................................... 5 
CHAPTER II LITERATURE REVIEW ......................................................................... 6 
Introduction ............................................................................................................... 6 
Aspergillus Infection .................................................................................................. 6 
Aspergillosis Treatment ............................................................................................. 8 
Who is at Risk? ........................................................................................................ 10 
Influence of Construction ......................................................................................... 12 
Healthcare Facility Guidelines ................................................................................. 13 
Infection Control Procedures .................................................................................... 13 
Previous Study ......................................................................................................... 15 
Summary ................................................................................................................. 21 
 
 x 
 
CHAPTER III  METHODOLOGY .............................................................................. 23 
Introduction ............................................................................................................. 23 
Original Experimental Equipment ............................................................................ 24 
Design of the Wood Barrier with an Opening ........................................................... 29 
Other Adjustment to the Equipment ......................................................................... 37 
Materials List and Comments on the Selection ......................................................... 47 
Test Procedure ......................................................................................................... 50 
Introduction .......................................................................................................... 50 
Procedure Test Number 1 ..................................................................................... 50 
Procedure Test Number 2 and 3 ............................................................................ 59 
Test Protocol ........................................................................................................ 59 
Data Collection ........................................................................................................ 60 
Analysis Methods .................................................................................................... 60 
CHAPTER IV RESULTS ............................................................................................ 61 
Introduction ............................................................................................................. 61 
Air Exchange Rate in Box ........................................................................................ 61 
Results for Test Number 1........................................................................................ 63 
Results for Test Number 2........................................................................................ 65 
Results for Test Number 3........................................................................................ 66 
Settlement Rate for Dust .......................................................................................... 67 
Summary ................................................................................................................. 70 
CHAPTER V CONCLUSIONS ................................................................................... 71 
REFERENCES ............................................................................................................ 73 
 
 xi 
 
LIST OF FIGURES 
 
 Page 
Figure 1. Aspergillus spore (after David Gregory and Debbie Marshall, 2012) ............... 7 
Figure 2. Diagram of the ventilation system ................................................................. 17 
Figure 3. Fungal growth at different incubation temperatures ....................................... 21 
Figure 4. Containment vessel design ............................................................................ 24 
Figure 5. Taped and sealed plastic sheeting .................................................................. 25 
Figure 6. MicroGard MGA7635 Air Filter ................................................................... 27 
Figure 7 Pressure gauge ............................................................................................... 29 
Figure 8. Selecting the wood ........................................................................................ 30 
Figure 9. Measuring the size of the barrier to fit in ....................................................... 31 
Figure 10. Making the wood barrier ............................................................................. 32 
Figure 11. Making the “opening” ................................................................................. 33 
Figure 12. Making the doorframe and operating the door ............................................. 34 
Figure 13. Materials used to make the door closer ........................................................ 35 
Figure 14. Straightening the iron wire and cool it down ............................................... 36 
Figure 15. Complete work of door on the barrier .......................................................... 37 
Figure 16. Powder funnel ............................................................................................. 38 
Figure 17. Drill a hole to fit the funnel on the top of box .............................................. 39 
Figure 18. Material used to fixing the wood box together ............................................. 39 
Figure 19. Filters used in the test .................................................................................. 40 
 xii 
 
Figure 20? Picture of filter contaminated with cornstarch ............................................. 41 
Figure 21? Cornstarch size distribution after (Paterson et al., 2001) .............................. 42 
Figure 22. Talc Powder used in the experimental work ................................................ 43 
Figure 23. Talc Powder - particle size distribution........................................................ 44 
Figure 24. Equipment assembled .................................................................................. 45 
Figure 25. Chamber B base view after assembly .......................................................... 46 
Figure 26. Material used .............................................................................................. 48 
Figure 27. Air filter shown in a flexed position ............................................................ 49 
Figure 28. C-clamp in place to hold the chambers still ................................................. 51 
Figure 29. Top filter ..................................................................................................... 52 
Figure 30. Bottom filter ............................................................................................... 53 
Figure 31. Fixing the cover board................................................................................. 54 
Figure 32. Weigh 1.0 g powder – Sona 2007 Scale accuracy ± 0.05 grams ................... 55 
Figure 33. Using the powder tunnel to place the material ............................................. 56 
Figure 34. Air pressure gauge ...................................................................................... 57 
Figure 35. Test 1 Setup and in progress ........................................................................ 58 
Figure 36. Test One - bottom filter optical microscope view – small scale.................... 63 
Figure 37. Test One - bottom filter optical microscope view – large scale .................... 64 
Figure 38. Test Two - bottom filter optical microscope view – small scale ................... 65 
Figure 39. Test Two - bottom filter optical microscope view – large scale .................... 66 
Figure 40. Test Three - bottom filter optical microscope view – small scale ................. 67 
Figure 41. Test Three - bottom filter optical microscope view – large scale .................. 68 
 xiii 
 
Figure 42. Stokes Law - Settling Velocities – Talc ....................................................... 69 
 
 xiv 
 
LIST OF TABLES 
 
 Page 
Table 1.  Invasive Aspergillosis in Transplant Recipients (Singh & Paterson, 2005) ....... 9 
Table 2.  Infection Agents - health care acquired .......................................................... 12 
Table 3.  Values of the global indices for the case with grille diffusers ......................... 18 
Table 4.  Values of the local indices in three locations for the 13 cases with diffusers .. 18 
Table 5.  Material and equipment list ........................................................................... 47 
Table 6.  Test Protocol for Three Tests ......................................................................... 59 
Table 7.  Air Flow Rate Determination......................................................................... 62 
 
 
 
 
 
 
 1 
 
CHAPTER I  
INTRODUCTION  
 
BACKGROUND TO THE STUDY 
Healthcare acquired infections are responsible for tremendous morbidity and 
mortality for patients at risk in hospitals. The Center for Disease Control and Prevention 
(CDC) estimate that approximately 10% of patients who are admitted to hospitals in 
United States will suffer from healthcare acquired infections. This results in millions of 
unwanted infections every year. Nosocomial infections and hospital acquired infections 
can be devastating to a patient, especially for an immunosuppressed patient, resulting in 
death or long term disability. Such infections include fungal and bacterial infections and 
are aggravated by the reduced resistance of individual patients. “Invasive Aspergillosis is 
one of the most opportunistic fungal infection among immunocompromised host, with a 
357% increase in death rates reported in the United States from 1980 to 1997, and the 
most common cause of invasive Aspergillus is Aspergillus fumigatus” (Panckal, Imhof, 
Hanley, & Marr, 2006).  
The trend in mortality associated with Aspergillosis has demonstrated an almost 
exponential increase, peaking in 1995 at 0.42 deaths per 100,000 of the population. 
Recent advances in antifungal drugs have reduced the increase in the death toll, but the 
disease is still persistent and problematic. Airborne transmission of the fungi can happen 
when the carrier of those infectious spread infected aerosol particles near the patients, or 
into the air handling system for the patients. Also, some micro-organisms can be brought 
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long distances due to air currents and can be inhaled by a high risk patient without 
having been in direct contact with a carrier, which is the problem associated with 
construction related dust. This work that deals with the movement of air particles 
contains specifics about infections with unknown origins (McNeail et al., 2001). 
When construction work is happening in or around hospitals, there is a patient 
risk from the spreading of dust from the construction that may contain fungi and 
bacteria. Patients are risk of infection whenever they are in hospital, but there is a higher 
risk of infection when construction is occurring in the hospital, especially for at risk 
patients. Teeter (2012) notes from work by L. Old that “more than 2 million patients 
admitted to acute care U.S. hospitals develop one or more nosocomial infections, and 
approximately 90,000 people die from complications associated with nosocomial 
infections, and approximately 5,000 deaths attributed to construction or maintenance 
related activities.” In addition to reducing the spread of infection, contractors and 
hospital staff need to make sure the containment of dust created by construction work is 
properly controlled at the source. Since 1978, construction related Aspergillus infections 
had been reported, those outbreaks of invasive Aspergillosis have been associated with 
construction activities including new construction, construction renovation and 
expansion. Fungal infection control is an urgent topic for both construction industry and 
healthcare facility management personal. 
In order to make sure that patients at risk, staff and even visitors are not 
negatively affected by the construction work, diligent planning and strictly controlled 
execution during construction work are required. Current protection measures on 
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construction infect control including plastic sheets that separate construction work from 
hospital area, which is supposed to be effective with proper design. However, the barrier 
between construction area and hospital are not always as successful as the previous 
studies proved. There are still possible ways for dust from construction site to be 
transmitted into hospital, therefore this study will look at the movement of dust through 
breaks in the barrier system. 
This chapter presents the problem statement, research objectives, hypothesis,  
PROBLEM STATEMENT 
This study addresses a research area related to the movement of dust particles 
from a construction area into a non-construction area. This study will measure the 
efficiency of a plastic barrier fitted with a door that is situated between the construction 
area and the hospital in stopping the transmission of dust particles. Talc is used as the 
substitute to dust particle 
RESEARCH OBJECTIVES 
The primary research area of this study is to determine the movement of dust 
particles in the size of 1 to 5 microns through the plastic barrier with an opening under a 
defined set of standard air flow conditions.  
HYPOTHESIS 
A test of construction barrier walls, with openings, using a differential pressure 
of 105 kilopascals, will showing a maximum dust flow rate of 2 μg/L in the air flow.  
STUDY LIMITATIONS 
The study limitations are: 
 4 
 
• will measure particulate matter at a size of 12 micrometres using a count per 
square millimetre on the output filter of the test system 
• restricted due to mock containments constructed at the TAMU Architecture 
Ranch and adjusted at the TAMU Woodshop in April 2014 
• It is not known how many particles of Aspergillus spp. are required for the 
development of an Aspergillus infection. In part, this is because development of a 
patient infection is dependent not only on the number of spores, but also patient 
immune response to the spores.  
• Talc powder is assumed to represent both the fungal spores and the dust 
media on which it may be transported, but this is an area for future research to 
determine the properties, mass, density and size of hospital dust 
STUDY ASSUMPTIONS 
It is assumed that  
• the experiment is a measureable test resembling hospital dust transmission  
• the substance utilized to imitate dust is of correct representation and size 
• a study pressure of 105 kilopascals is representative of 90 metres per second 
wind storm, which is equivalent to fifteen pounds per square inch at two 
hundred miles per hour), which is higher than most recorded wind speeds in 
the USA, although the filtered media will reduce the impact 
• the impact of the filter is assumed negligible 
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SIGNIFICANCE 
A known relationship exists between construction activities and an increase in 
nosocomial infection. This study looks to see if the open door in a construction wall can 
be shown to present a dust transmission path.  
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????????II 
LITERATURE REVIEW 
 
INTRODUCTION 
This study includes a literature review that looks at the background information 
for hospital acquired infection, considers how construction activities are involved with 
nosocomial infections and especially focuses on the current procedures that have been 
used to protect patients at risk from dust contains pathogen that are created from 
construction work. The chapter outlines the problem of aspergillus infection,  
ASPERGILLUS INFECTION  
Aspergillus is a group of around 200 known fungi and most of it family are 
known to be detrimental to human health. Aspergillosis is the disease caused by 
Aspergillus fungi, and there are many kinds of Aspergillosis. For instance, one form is 
allergic bronchopulmonary Aspergillosis (also called ABPA) which causes allergic 
respiratory symptoms (wheezing and coughing), but not an actual infection. Expose to 
Aspergillus can also lead to invasive Aspergillosis, which may affect patients whose 
immune system may be compromised, such as following a transplant (Panckal et al., 
2006). In this condition, the fungus invades and damages tissues in the body. Invasive 
Aspergillosis most commonly affects one organ but can also cause infections in many 
other organs and spread throughout the body. Patients at risk including those with 
chronic granulomatous disease, leukemia, cystic fibrosis, chronic obstructive pulmonary 
disease, severe asthmatic fungal sensitivity, HIV, AIDS, and chemotherapy and 
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transplant patients. According to Center for Disease Control and Prevention, 88,000 
immune compromised patients died from healthcare acquired infection among two 
million acquired infections in hospital every year. Besides, more than half of these 
occurred with construction activities around the hospital. 
 
 
Figure 1 shows the picture of the Aspergillus spores from Franzblau (2012).  
 
Figure 1. Aspergillus spore (after David Gregory and Debbie Marshall, 2012) 
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Gregory and Marshall (2014) took this SEM image of Aspergillus mould 
producing spores in 2012. These authors noted “This is a commonly found mold and 
airborne exposure is ubiquitous in the indoor and outdoor environments – and usually 
does not lead to”. Franzblau (2012) notes that “Despite almost constant and widespread 
environmental exposure, this type of deep tissue infection with Aspergillus essentially 
never happens among persons with a normal immune system” 
This study looks at the transmission of dust particles that are capable of 
containing spores of Aspergillus that are disturbed during construction activities. The 
Center for Disease Control and Prevention (2014) notes that Aspergillus as “a common 
fungus that can be found in indoor and outdoor environments and normally human 
beings breathe in Aspergillus spores every day without being affected. Aspergillosis is a 
disease caused by this fungus and usually occurs in people with lung diseases or 
weakened immune system.” In addition, Aspergillus is usually found in soils, on plants, 
and decaying plant matter. It also can be found in household dust, construction-building 
material and even on some foods items. There are lots of different types of Aspergillus, 
but some of the more common ones are including Aspergillus Fumigatus, Aspergillus 
Flavus, Aspergillus Terreus, and Aspergillus Niger. 
ASPERGILLOSIS TREATMENT 
Although the Centers for Disease Control and Prevention provide guidelines to 
protect patients at risk from nosocomial infection, Aspergillosis infection is still a tough 
issue for healthcare industry and the treatments of Aspergillous even a with significant 
medical expenses are not always successful. The typical questions are: 
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• Why have outcomes been so bad and what is the impact of early diagnosis? 
• What are options for therapy? 
• Is disseminated infection or severely immune-compromised? 
• Can we do better in protection patient at risk? 
• What’s the important of role of combination therapy? 
• How can management strategies improve outcome? 
Table 1 shows the mortality rates from invasive Aspergillosis in transplant 
recipients from a paper by Singh and Paterson (2005). 
 
Table 1.  
Invasive Aspergillosis in Transplant Recipients (Singh & Paterson, 2005) 
Type of Transplant Incidence Range, % (Mean) Mortality (%) 
Lung 3-14% (6%) 68% 
Liver 1-8  (2) 87 
Heart 1-15 (5) 78 
Kidney 0-4 (1) 77 
Small bowel 0-10 (2) 66 
Allogeneic stem cell 5-26 (10) 78-92 
Autologous stem cell 2-6 (5) 78-92 
Nonmyeloblative stem cell 8-23 (11) 63-67 
 
 10 
 
Anaissie and Denning (2008) noted in their paper that Amphotericin B and 
Itraconazole are the only two antifungal agents that had been used for Aspergillosis 
treatment. However, the acute renal failure and hidden costs of toxicity indicate the 
treatment is not always successful and nor effective. Their data show that 212 out of 707 
adult patients receiving Amphotericin B had acute renal failure, and higher mortality 
exists as a result of acute renal failure is 54% against 16%.  
The following paper, by Bates et al. (2001), lists the key points and concerns of a 
24 hour continuous infusion Amphotericin B: 
• Dose escalated to 2 mg/kg/d when tolerated 
• Median duration of therapy 16 d (range 7- 72d) 
• Infusion-related reactions is 18% 
• >2-fold increase in creatinine is 16% 
• Dose limited toxicity is 1/33 
Concerns (Andes, 2003; Imhof, Walter, & Schaffner, 2003) are: 
• Limited efficacy data in documented infection 
• Poor efficacy of Amphotericin B in invasive Aspergillosis 
• Animal models: peak serum level/MIC best predictor of outcome 
WHO IS AT RISK? 
For people with a sound immune system who breathe in fungal spores or even 
stay for long time in contact with fungal spores or dust with fungal spores there are 
limited and low infection rates, but for people who born with weak immune system or 
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their illness lead to non-functional immune systems are more likely to develop a 
nosocomial infection in hospital. Such groups include: 
• people living with HIV/AIDS 
• organ transplant patients 
• stem cell transplant patients 
• cancer patients 
• people taking medications that weaken their immune systems 
Healthcare associated infections cost numerous lives and billions of dollars to the 
United States healthcare system. Hospital Acquired Infections (HAIs) facts show the 
impact of these infections: 
• Every day in the United States 270 people die from a healthcare associated 
infection, which is 3 times the number of people who die in a car accident 
each day 
• 1,737,000 people will get an HAI in the U.S. in 2012 
• 40 billion dollars cost in the U.S. caused by HAIs, which is equal to the 
Federal Highway budget for 2014 
• Healthcare associated infections are the fourth leading cause of death in the 
United States 
• 10% of patients will get a healthcare associated infection 
• On average, healthcare associated infections increase hospital stays by 8 
days and HAIs keep a patient in the hospital 13 days longer 
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• Healthcare associated infections keep cancer patients in the hospital an 
average of 30 days longer 
INFLUENCE OF CONSTRUCTION 
Any construction system that will reduce this cost is worth investigation to 
provide a better health care system. Berg (2012) notes that construction related 
healthcare acquired infection are usually caused by fungi (most common one is 
Aspergillus). Table 2 lists the most commonly seen etiological agents from this paper. 
Table 2.  
Infection Agents - health care acquired 
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HEALTHCARE FACILITY GUIDELINES 
Construction Infection prevention guidelines required construction activities 
around hospital area to be both effective and harmless to the patients at risk. The 
hospital’s primary obligation is to provide for patient safety within the most risk free 
environment possible. Some companies have already developed their own “practice 
guidelines” and compete with each other to be knows as providing for the best practices 
in healthcare construction industry. 
As an example, one such company is The Linders Health Institute, which 
provides ICRA/PCRA training courses. It offers courses to Architects, Engineers, 
Contractors, IAQ, Legal, CIH, IICRC, HVAC, including CM, PM personal. This group 
specifically relates to healthcare and best practices for construction of medical buildings. 
Some other institutions provide educational programs for healthcare infection control 
during construction activities. 
INFECTION CONTROL PROCEDURES 
The Infection control risk assessment method has the following key points for 
construction activities undergoing around the hospital area: 
• Ensure patient safety 
• Personal protective equipment 
• Containment barriers 
• Dust and debris control 
• Anteroom construction 
• Containment of infectious agents. 
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As noted by the AIA (2006): 
“An ICRA is multidisciplinary, organizational, documented process that 
after considering the facility’s patient population and program, which is 
focusing on reduction of risk from infection; Acts through phases of facilities 
planning, design, construction, renovation, facility maintenance, and 
coordinates and weighs knowledge about infection, infectious agents, and 
care environment, permitting the organization to anticipate potential 
impact” 
The ICRA matrix is a published assessment method that is widely accepted 
by engineers and architects, and is one effective method for completing an 
ICRA. Although the ICRA does not have to be done as a matrix, it does help 
non-clinical staff understand management of patient groups without 
requiring specific diagnoses. 
Each facility should categorize patients per group within a specific patient 
population. The development of the "patient risk groups" is quite relative--
and the criteria are dependent on the facility's mix of patients. Nursing 
homes and ambulatory care delivery sites have very different populations, 
and risk is relative.” 
The key point is to stop the movement of fungi from the construction area to the 
ward areas for the at risk patients. 
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PREVIOUS STUDY 
The study by Villafruela, Castroa, San Joséa, and Saint-Martinba (2012) entitled 
“Comparison of air change efficiency, contaminant removal effectiveness and infection 
risk as IAQ indices in isolation rooms” simulated a hospital building and focused on the 
risk of spreading infections from the ventilation system into the hospital building. As the 
nosocomial infection related morbidity and mortality is increasing and ventilation related 
transmission becoming a main factor of spreading infectious diseases, this research team 
was trying to find the correlations between the configuration of the air diffusers and the 
infection risk. This paper reviewed different methods and technologies in the previous 
studies of this problem, but because of the high expense in supporting the technology or 
ineffective results from the prior research study, more economy and feasible research 
was required to provide a more effective design of a ventilation system to help reduce 
this infection risk. Therefore, the main objective of this study is analysis the influence of 
the position of air inlets and outlets to compare the different configuration quantitatively. 
In this study, the research team is using a Computational Fluid Dynamics (CFD) tool for 
predicting the movement of the air in ventilated spaces. This study used CFD to design a 
ventilation systems of a simulated room in a hospital building, and the validation was 
based on the comparison to experimental data obtained by means of photo-acoustics 
spectrometry.  
Three types of indices are applied to the designed ventilation system, the first one 
is quantifying the capacity to renew the air, second one is quantifying the capacity to 
remove a contaminant, and the third one is quantifying the risk of airborne infection. In 
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this study, the three sufficiently general indexes are used to judge the performance of a 
ventilation system quantitatively; they are air change efficiency and local air change 
index, contaminant removal effectiveness and local air quality, and infection risk. The 
data obtained was reviewed using a mathematical model. In the experiment, the team 
used three different diffusers (grille, square, swirl), and the team measured the air 
change efficiency 
p
aε , the infection risk 100lP , and the contaminant removal effectiveness 
p
caε , including one group that both considering deposition on the walls and the viability 
of micro-organisms ccε , and the other group only consider the deposition on the walls cbε , 
and the last group considered either of them cbε . Therefore the differences of these three 
group data can show the relations between different depositions and micro-organisms. 
Figure 2 shows a diagram of the model ventilation system used in their research work. 
The real issue here is the supply pointing directly onto the patients bed, with a dust fall 
rate in the typical range the ventilation arrangement is not ideal.  
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Figure 2. Diagram of the ventilation system 
 
 
 Table 3 shows the values of the global indices with the grille diffuser.  
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Table 3.  
Values of the global indices for the case with grille diffusers 
 
 
 
 Table 4 shows the values of the local indices in three locations for the 13 cases 
with diffusers. 
Table 4.  
Values of the local indices in three locations for the 13 cases with diffusers 
 
 
This study data in Table 3 shows: 
1. the best air change efficiency group no.1 and 12 had the air flow 
completely sweeping the room upon entry  
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2. the best contaminant removal group no. 2 and no. 5 indicated that the 
best way to remove contaminant is to set the air inlets in the ceiling in 
front of bed and the air outlet in the ceiling precisely above the patient 
3. there’s no significant relation between deposition of particles and 
contaminant change efficiency,  
4. the difference between cbε ,  and ccε ,  is also very small. So there’s only a 
relation between infection risk and contaminant removal effectiveness, 
ccε  
The study data in Table 4 shows: 
5. the researcher concluded that the relation between the local air change 
efficiency caε  and infection risk is significant 
6. In addition, there is significant difference of infection risk from different 
configuration of air inlets and outlets. 
7. Besides, comparing three different diffusers, there’s big difference in the 
performance of the different configurations.  
It is not enough only to consider air change efficiency to evaluate the 
effectiveness of the protection system for nosocomial infections, the study demonstrated 
that the position of air inlets and outlets, contaminant removal effectiveness, viability of 
the pathogens or exposure time, ctε , are related in a complex system, all of the variables 
can provide useful information to evaluate the effectiveness of ventilation system.  
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Boff, Brun, Miron, Zoppas, and Pasqualotto (2012) note that while environment 
air monitoring is a common practice in research institutions, not enough attention is paid 
to the temperature of incubation, and most of the study used room temperature, typically 
20 degrees Celsius for research. This research team compared different incubation 
temperature on pathogenic fungi, especially Aspergillus species that has serious 
influence on the nosocomial infections. The study conducted in a Brazil hospital started 
in September 2010, using Andersen N-6 air sampler in ICU and hematopoietic stem cell 
transplantation units. Two different temperatures were used in the experiment (25 and 
35-40 degrees Celsius) with observation of the fungal growth for 7 days, and using the 
classical mycology method to identifying the genus level.  
Yeasts and mould used in the experiment all belong to Aspergillus genus, and 
environment fungi included species of cladosporium, penicillium, and trichoderma, 
dematiaceous fungi and sterile filamentous fungi. The quantitative results were obtained 
by dividing the total number of fungal colonies as shown on Figure 3.  
 
 
 21 
 
 
Figure 3. Fungal growth at different incubation temperatures 
 
 
This study shows that Aspergillus section Fumigate grows more quickly at the 
incubation of 35-40C, rather than in the 25C. However not all the Aspergillus species are 
affected by temperature, Aspergillus section Flavi was not influenced by incubation 
temperature. Therefore, at 25C a hospital could potentially reduce the presence of 
Aspergillus section Fumigati, which may help control the spread of Aspergillus related 
disease in hospital.  
SUMMARY  
Hospital acquired infections are a problem for all people; they kill many and increase 
the cost of hospitals for all. The work by Boff et al. (2012) clearly points to the 
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computation fluid dynamics problem as the key element to understanding this problem 
and working towards a system that reduces the rate and number of infections.  
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CHAPTER III  
METHODOLOGY 
 
INTRODUCTION 
The purpose of this experiment is to facilitate healthcare construction in 
developing a more effective barrier or inspiring new techniques to protect patient with 
compromised immune system and therefore reducing the risk of one of the most 
common nosocomial infections - Aspergillus infection. This experimental work is based 
on the previous study methods that had been used in the study entitled “Comparison Test 
for Infection Control Barriers for Construction In Healthcare” (Bassett, 2013).  
The concept of this experiment is to simulate a construction site area and a 
hospital area with a barrier between them to testing the particle pass through. The goal of 
the previous research was -“being tested is the typical plastic sheeting barrier method 
commonly used in hospitals during construction. The purpose is to determine how well 
this sheeting system upholds and maintains its barrier, and how many particles are 
actually transmitted through the barrier (Bassett, 2013). 
This chapter will detail the existing equipment and the changes made to the study 
chamber. The methodology is: 
• Summarize  the design of the existing equipment  
• Detail the design and construction of the new wooden barrier with an opening 
• Data collection 
• Analysis methods 
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ORIGINAL EXPERIMENTAL EQUIPMENT 
 The original chamber used for the testing of the barriers was developed by 
(Bassett, 2013) who looked at the movement of dust particles through a plastic barrier 
sheet taped down with blue painters tape. Figure 4 shows the general arrangement.  
 
 
 
Figure 4. Containment vessel design 
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 The rather simple plastic barrier stopped all dust movement, which was not 
expected due to the poor quality of the tape. Figure 5 shows the lower half of the test 
chamber with the plastic barrier installed.  
 
 
 
Figure 5. Taped and sealed plastic sheeting 
 
 
 26 
 
 This experimental work will replace the plastic barrier with a simple wooden 
wall with a door installed in the wall. As shown in the figure above, the previous 
equipment is made of two-separated wood boxes with dimensions 267 mm by 304 mm 
by 457 mm. The chamber was constructed at woodshop of Architecture school in Texas 
A&M University. One of the chambers represents the hospital area, and the other 
represents the construction site area.  
For the infection control barrier material, plastic sheeting was used with a 
thickness of 25.4 microns. Painters tape was also used for bond the overlap of the plastic 
sheeting, and fix the plastic barrier in between the two simulated boxes to simulate the 
infection control barrier. 
The purpose of this experiment is to provide a positive air flow from upper 
Containment A to the lower Containment B. This allows for a measurement of particles 
that may have successfully passed through the barrier. An air pressure system was 
designed for each side of the containment vessel. A positive air pressure system is placed 
into the top of Containment A, where the dust will be located. This system forces air into 
Containment A.  
Figure 6 shows a MicroGard MGA7635 air filter is inserted into the top of 
Containment A.  Haberl (2013) suggested the use of the automotive air filters to Bassett. 
She selected a filter that would lay flat on the base of the lower containment vessel to 
maximize the chances of trapping any particulate matter that passes the barrier. 
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Figure 6. MicroGard MGA7635 Air Filter 
 
 
This filter is lined with a rubber gasket to provide a tight seal for eliminating 
leakage of air. The dimensions of the filter, 248 mm by 178 mm, were cut from one face 
of the containment chamber A. The filter could then be tightly fit into the top of the 
containment chamber.  
An air pressure-regulating valve controls the flow of air pushed through the filter 
into the containment chamber A and into the barrier to mimic airflow of a construction 
zone. 
 28 
 
Containment chamber B has a filter located on the bottom face to determine the 
particulate matter that passed the barrier during the test. This filter would catch and trap 
particles that may be coming through the wall test section. The dimensions of the filter, 
248 mm by 178 mm, were cut out of one face of containment chamber B. The filter 
could then be tightly fit into the experimental chambers. 
The conceptual idea for the containment vessel is to introduce an overpressure of 
105 kilo Pascals into the chamber A and measure the materials that pass through the 
barrier and fall onto the lower filter in chamber B. The arrangement is a vertical 
arrangement so that a particle that passes through the barrier should fall onto the base, 
which is filtered using a Microgard filter.  
  Figure 7 shows the pressure gauge used to measure the inlet pressure of the 
incoming air.  
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Figure 7 Pressure gauge 
 
 
DESIGN OF THE WOOD BARRIER WITH AN OPENING 
The simulated infection control barrier that has been used in between 
“construction area” and “hospital area” was originally plastic with no openings. A new 
barrier was constructed with a mock door covering five percent of the surface area of the 
wall.  
A flat sheet of wood was selected for making the barrier in between the two 
containments. This material has to be not too thick for practical consideration, but stiff 
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enough to withstand the air pressure and the construction of the door. Figure 8 shows the 
wooden sheet selected to make the barrier. 
 
 
 
Figure 8. Selecting the wood 
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Figure 9. Measuring the size of the barrier to fit in 
 
 
The wood sheet is made as the same size as the flange between two boxes, which 
is 381 mm by 381 mm and square. Figure 10 shows the cutting of the wooden barrier.  
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Figure 10. Making the wood barrier 
 
 
The door takes up 5% of the total barrier area. Since the total area of the barrier 
would be 145 by 161 mm, by calculation the door size would roughly be 6 mm by 6 mm 
and square. Figure 11 shows the opening constructed for the doorway.  
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Figure 11. Making the “opening” 
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Figure 12. Making the doorframe and operating the door 
 
 
A doorframe  is made by cutting the same type of plywood at size of 7 mm by 7 
mm, once the doorframe is set onto the wall. Black tape is used to add the “door” to the 
wall. A lifting wire was manufactured to make sure the door is fully closed during the 
experiment or open as required in the experimental protocol.  
Figure 13 shows the base material used to make the door closing wire 
arrangement. A looped wire was heated and then stretched to form a straight thick wire 
able to apply the necessary load and not bend. Figure 14 shows the wire straightening 
and cooling.  
 35 
 
 
Figure 13. Materials used to make the door closer 
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Figure 14. Straightening the iron wire and cool it down 
 
 
 
After the door is ready, the iron wire to control the door open and close during 
the experiment is installed in the containment vessel A, as shown on Figure 15. 
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Figure 15. Complete work of door on the barrier 
 
 
OTHER ADJUSTMENT TO THE EQUIPMENT 
After the door is constructed on the barrier, a change was made to the top of the 
box to provide an access point to add powder during the tests. A plastic outlet was added 
on the construction box to fix a powder tunnel for, which can add the powder at any time 
during the test. This plastic tunnel has been fixed into the hole drilled on the top of the 
test vessel. Figure 16 shows the powder funnel prior to construction.  
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Figure 16. Powder funnel 
 
 
 Figure 17 shows the construction of the hole in the top lid of containment 
chamber A. The dust vessel is not in the same relative corner as the door to avoid dust 
short circuiting the system.  
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Figure 17. Drill a hole to fit the funnel on the top of box 
 
 
Figure 18 shows the tools used to assemble the two chambers.  
 
Figure 18. Material used to fixing the wood box together 
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 Figure 19 shows the filter used in the test arrangement.  
 
 
Figure 19. Filters used in the test 
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Four filters will be used through the whole experiment, two for each experiment 
(one for the top construction simulated box and the other for the bottom hospital 
simulated box). The top filter was used for all experiments. 
The powder used by Bassett (2013) was noted by the manufacturer as being 
essentially cornstarch. Vitha (2013) noted the diameter at about 12 micrometres as 
shown on picture of a filter contaminated deliberately by Vitha with the powder. Figure 
20 shows the filter contaminated with corn starch by Vitha from the study by Bassett 
(2013). 
 
 
 
Figure 20 Picture of filter contaminated with cornstarch 
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Cornstarch has a grain size distribution in the range of 1 to 27 microns from 
recent work completed by Paterson, Hardacre, Li, & Rao (2001) on cornstarch from 
Australian and New Zealand. Figure 21 shows the distribution of diameters measured by 
these researchers.  
 
 
 
Figure 21 Cornstarch size distribution after (Paterson et al., 2001) 
 
 
A sample of the powder from the same manufacturer was obtained for this set of 
experiments. The MDS data shows that the manufacturer has substituted talc powder for 
the corn starch used in the earlier powder. The reason for the change is not known.  
Figure 22 shows the powder.  
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Figure 22. Talc Powder used in the experimental work 
 
 
Three samples of Talc dust were tested by the EPA for particle size distribution. 
Figure 23 shows the results of the EPA analysis at three stages of manufacture, crushing, 
grinding and bagged. The difference in the mean size is evident in the graph. The mean 
size in the bagged sample is 2 to 10 micrometres (U.S. Environmental Protection 
Agency, 2009).  
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Figure 23. Talc Powder - particle size distribution 
 
 
The two materials have a similar mean particle size as would be expected given 
the use of the materials. The corn starch has a more uniform distribution.  
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Figure 24 shows the two chambers assembled in the final configuration. On the 
top of the chamber A the powder tunnel and one iron wire control stick for the door are 
visible. The opening for the air inlet is shown in the center of the picture. 
 
 
 
Figure 24. Equipment assembled 
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Figure 25 shows the base of Chamber B after assembly and installation of the 
lower filter. Two beams of wood are placed under the whole assembly to keep it off the 
ground so the dust from the ground will not be affects the result of the test. 
 
 
 
Figure 25. Chamber B base view after assembly 
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MATERIALS LIST AND COMMENTS ON THE SELECTION  
All the materials for the test equipment were sourced locally. Table 5 lists the 
materials and the equipment used during the tests and the construction work related to 
the openings on the plywood barrier. 
 
 
Table 5.  
Material and equipment list 
Materials used in Experiment Equipment used in Experiment  
Material  Comment  Tool  Comment  
Plywood  9 mm oak (barrier) Table Saw Trim cut plywood 
C-clamp 4 on each corner to 
fix the containment 
 
Electrical scale Measure 0.1g 
powder  
Nails  Bostitch Air gun  Drill Press Drill holes for 
minor fittings 
Tape Fix the door on the 
barrier 
Air Pressure 
Regulating Valve 
Supply air at 105 
kPa 
Powder Talc Powder C-clamp Fix on the corner 
 
 
 
Figure 26 shows the equipment used during the experimental work. Figure 27 
shows the air filter used for the experiments.  
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Figure 26. Material used 
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Figure 27. Air filter shown in a flexed position 
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TEST PROCEDURE 
Introduction 
The test procedure is similar to the procedure used by Bassett (2013) when 
testing a fully sealed barrier. Three tests of the door system are used. The tests are 
numbered Test 1 to Test 3. This section outlines the test procedures. The test procedures 
are controlled by the access requirements for the woodshop which is only open from 8 
am until 5 pm on work days.  
Procedure Test Number 1 
Test procedure for test number 1 is: 
1. Clean two containment chambers thoroughly in order to remove the original 
dust exist in the containment that could effect on the final result to the test 
2. Fix the two containments together with the barrier (that has the door on it) 
in between by using a set of C-clamps, and check the control bar works 
Figure 28 shows the two chambers clamped together 
3. Put the filters on the top and bottom of two containments as shown in Figure 
29 and Figure 30 
4. Cover the top filter with cover board with a hole to fit the air flow hose, and 
use nails to fix it tight as shown in Figure 31 
5. Weigh out 1.0 g of powder and put the powder in the top containment 
through  the powder tunnel as shown in Figure 32 and Figure 33 
6. Fix the pressure gauge on the air hose and use a cable tie to keep the air 
hose on all the time, and adjust the air flow as shown in Figure 34 
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Figure 28. C-clamp in place to hold the chambers still 
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Figure 29. Top filter 
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Figure 30. Bottom filter 
 54 
 
 
Figure 31. Fixing the cover board 
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Figure 32. Weigh 1.0 g powder – Sona 2007 Scale accuracy ± 0.05 grams 
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Figure 33. Using the powder tunnel to place the material 
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Figure 34. Air pressure gauge 
 
 
7. Place the air supply into the top of the containment chamber A and run the 
test as shown in the Figure 35. 
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Figure 35. Test 1 Setup and in progress 
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The test containment vessel was placed in a quiet corner of the woodshop so it 
would not be disturbed during the test procedure.  
Procedure Test Number 2 and 3 
These two test procedures were the same as test procedure 1.  
Test Protocol 
The protocol for the three tests is summarized in Table 6. 
 
 
Table 6.  
Test Protocol for Three Tests 
Description Unit Value 
Duration Test 1 hours 72 
Duration Test 2 hours 48 
Duration Test 3 hours 24 
Test 1 door closed  
Test 2 door opened  3 times in first 24 hours for 
5 minutes each time 
Test 3 door opened 6 times in 24 hours with 3 
minutes each time 
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DATA COLLECTION 
Data collection uses the MicroGard filters. 
ANALYSIS METHODS 
A count of the particles per square metre will be made on the filters. 
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CHAPTER IV 
RESULTS 
 
INTRODUCTION 
This chapter presents the results for the experimental work and the data analysis.  
The results are: 
• Determination of the air exchange rate 
• Test One Results 
• Test Two Results 
• Test Three Results 
• Dust Settlement Rate Analysis 
• Summary 
AIR EXCHANGE RATE IN BOX 
One of the key criteria for human health is an adequate supply of fresh air, this is 
usually expressed in air changes in a room in a certain period. A simple experiment was 
completed to determine the rate of supply of the air from the air vessel at the nominated 
supply pressure of 150 kilo Pascals. A plastic bag was used to measure the air flow rate 
from the air hose.  
Table 7 summarizes the air flow determination rates for the test chamber.  
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Table 7.  
Air Flow Rate Determination 
Test Number Volume Bag (L) Time (second) Rate of air (L/s) 
1 240 210 1.1 
2 240 240 1 
Average 240  1.05 
 
 
 
The volume of the test chamber A is determined from the inside dimensions 267 
mm by 304 mm by 457 mm, which is 37.1 litres. The air exchange rate is 106 times per 
hour. The air flow rate is 1 litres/second, which given the area of the box provides an 
average air velocity of 12 millimetres per second.  
The maximum allowable concentration of particulate matter is 150 micrograms 
per cubic metre of air in the USA (EPA). The total volume of air to pass through the test 
chamber in 24 hours is 86400 litres, which provides for a total of 0.013 grams of 
particulate matter at this concentration level. The supplied particulate matter is 1 gram or 
77 times the legal amount.  
BHP Billiton (2014) in preparing the environmental impact statement for 
Olympic Dam measured the dust concentrations in a rural environment at 10 micrograms 
per cubic metre. The BHP measurements are clean rural air and the EPA standard is the 
peak allowed in the USA.  
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A typical low velocity dust collection system to move breathable particles to the 
collection system requires a velocity of 9.2 metres per second to keep the fine particles 
in suspension.  
RESULTS FOR TEST NUMBER 1 
 The first test is with the door closed. The test period was 72 hours. Figure 36 
shows the bottom filter after three days of flow. 
 
 
 
Figure 36. Test One - bottom filter optical microscope view – small scale 
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 There are no visible particles on the filter. Figure 37 shows the filter at a higher 
magnification. There are no visible particles.  
 
 
 
Figure 37. Test One - bottom filter optical microscope view – large scale 
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RESULTS FOR TEST NUMBER 2 
The second test was for 48 hours, the door was opened a total of three times for a 
total period of 15 minutes. Figure 38 shows the second filter from the bottom of the test 
chamber using an optical microscope. No particles are visible.  
 
 
 
Figure 38. Test Two - bottom filter optical microscope view – small scale 
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Figure 39 shows the same filter at a higher magnification. No particles are visible.  
 
 
 
Figure 39. Test Two - bottom filter optical microscope view – large scale 
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RESULTS FOR TEST NUMBER 3 
The third test is with the door open six times for a total of 18 minutes. The test 
period was 24 hours. Figure 40 shows the bottom filter after one day of flow. No dust is 
visible.  
 
 
 
Figure 40. Test Three - bottom filter optical microscope view – small scale 
 
 
Figure 41 shows the same filter at a higher magnification. No dust is visible. 
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Figure 41. Test Three - bottom filter optical microscope view – large scale 
 
 
SETTLEMENT RATE FOR DUST 
Dust settles if suspended in air. The rate of settlement is controlled by Stokes 
Law. The applicable equation for settlement of particles in dry air is given in equation 
(1): 
22 ( )
9
s ar gV ρ ρ
µ
−
=       (1) 
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 Where V is the velocity in m/s, r is the radius of the dust particle, g is 9.806 m/s. 
µ  is the viscosity of the air, sρ  is the density of the solid and aρ  is the density of the 
air. A simple FORTRAN program was developed to determine the settling velocity for 
different sized talc particles in air using Stokes Law. The Reynolds number for the 
settlement of Talc powder in air was less than one, therefore the flow is laminar and 
Stokes law holds.  
 Figure 42 shows the settling velocity for the particle diameter range of 1 to 10 
micrometres.  
 
 
 
Figure 42. Stokes Law - Settling Velocities – Talc 
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SUMMARY 
 Spores are carried on dust particles. These spores can cause serious disease and 
death. This study has looked at the use of a test chamber to model the movement of dust 
through a construction wall. The results in this series of experiments show that under the 
standard operating conditions, no measureable dust passed through the door into the 
second chamber. There are different theories as to why this result is observed, but the 
two problems are the specific density and size of the particles is higher than naturally 
occurring particles and the dust movement is by air circulation alone.  
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CHAPTER V 
CONCLUSIONS 
This research expands our prior work to evaluate the effectiveness of a plastic 
barrier to limit the movement of dust from a construction zone next to or attached to a 
hospital to a clean hospital zone. Observational data suggests that increased risk of 
fungal disease, such as Aspergillosis, occurs with increased level of construction dust. 
The dust expected to be generated by construction is a heavy particulate matter, such as 
silica, gypsum or equivalent due to the nature of construction materials. The first study 
used a corn starch to model a dust particulate movement from a construction side to a 
clean side in a specially constructed chamber set. This first study found no dust 
movement.  
This second study changed the barrier arrangement from a fully sealed plastic 
sheet to a wooden wall with a door representing five percent of the wall area. The door 
size was six millimetre square. An alternative dust material was used for this set of 
experiments, a talc powder. Three tests of the barrier system were made with the door in 
test 1 closed, in test 2, open for a total of 15 minutes in 48 hours and for test 3 the door 
was open for a total of 18 minutes in 24 hours. No dust was observed to move from the 
construction chamber to the clean chamber during the test.  
An analysis of the settling velocities of the for the size and density of talc 
particles shows that the material will settle with a rate of 1 to 7 millimetres per second in 
still air. The Reynold’s number for the dust settling in chamber is less than one, so the 
assumption of laminar flow conditions is reasonable. The air exchange rate for the 
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system is 106 times per hour, in excess of normal rates in a hospital setting. There 
appear to be a number of issues related to the experimental procedure and the results for 
this study. The first issue is the material used to represent the dust that moves the spores. 
The Talc powder may by denser than the typical house or hospital dust, although given 
the likely source of construction dust this would be an interesting result. The second 
issue is the lack of movement of the dust given the relative level of air movement.  
The conclusion reached is that construction type dust is difficult to move in air 
systems typically used in hospitals. This conclusion points to two potential areas of 
future study, the composition of dust from hospital settings, the relative density and size 
of the dust generated in the adjacent hospital construction. The velocity of the air 
movement through the construction that leads to increased infection levels. Industry 
practice suggests a velocity of nine metres per second is required to keep particulate 
matter in suspension in air. This is a very high velocity for a ventilation system.  
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